PLoS ONE· 2026Q1
Comparison of two repetitive peripheral magnetic stimulation protocols for upper trapezius myofascial pain syndrome: A randomized trial
- 0citations
- Q1SCImago
- 2026year
Short summary
A 4-week trial (n=66) found no significant difference in pain reduction (VAS) between 10-minute and 15-minute repetitive peripheral magnetic stimulation (rPMS) protocols for upper trapezius myofascial pain syndrome.
AI-generated from the title and abstract; the full text is not read.
Key points
- A 4-week randomized trial compared 10-minute and 15-minute rPMS protocols for upper trapezius myofascial pain syndrome (n=66).
- Both protocols, combined with stretching, led to significant improvements in pain (VAS), pressure pain threshold (PPT), and neck disability (NDI) over time.
- No significant between-group differences were found for VAS, PPT, or NDI at week 4.
- The adjusted between-group difference in VAS at week 4 was -0.27 (p=0.43).
AI-generated from the title and abstract; the full text is not read.
Abstract
Background Upper trapezius myofascial pain syndrome (MPS) is a common contributor to chronic neck pain and functional limitations. Repetitive peripheral magnetic stimulation (rPMS) has emerged as a non-invasive neuromodulatory intervention; however, the optimal stimulation duration remains uncertain. Clarifying duration-dependent effects is important for informing parameter standardization in rehabilitation practice. Methods This single-centre, assessor-blinded randomized trial enrolled adults aged 18–55 years with chronic (≥ 3 months) upper trapezius MPS and baseline Visual Analog Scale (VAS) scores ≥ 4. Participants were randomly assigned in a 1:1 ratio using permuted blocks to receive either a 15-minute or 10-minute rPMS protocol once weekly for 4 weeks, in addition to standardized stretching exercises. The primary outcome was pain intensity measured using the VAS. Secondary outcomes included Pressure Pain Threshold (PPT) and the Neck Disability Index (NDI). Assessments were conducted at baseline, week 2, and week 4 by a blinded assessor. Analyses followed the intention-to-treat (ITT) principle using linear mixed-effects models (LMMs) with fixed effects for group, time (baseline, week 2, week 4), and the group-by-time interaction. Results Of 83 individuals screened, 66 were randomized (33 per group) and included in the ITT analysis. Baseline characteristics were comparable between groups. LMMs demonstrated significant improvements over time in VAS, PPT, and NDI (all p < 0.001), with no significant group-by-time interactions. At the prespecified primary endpoint (week 4), VAS decreased from baseline by 4.87 points in Protocol A and 5.02 points in Protocol B. Across both groups, PPT increased by 2.51 kg/cm² and NDI decreased by 9.15 points. The adjusted between-group difference in VAS at week 4 was −0.27 (95% CI −0.95–0.40; p = 0.43), indicating no significant difference between protocols. Similarly, no significant between-group differences were observed for PPT (0.17, 95% CI −0.70–1.03; p = 0.71) or NDI (−0.64, 95% CI −3.29–2.02; p = 0.64). Conclusions Both treatment durations were associated with significant short-term improvements in pain intensity, pressure pain threshold, and neck-related disability. No significant between-protocol differences were detected within the present sample and follow-up period. These findings suggest that a 10-minute rPMS protocol may be a practical option for clinical rehabilitation settings. Trial registration This trial was prospectively registered with the Thai Clinical Trials Registry (Ref: TCTR20250929011; https://www.thaiclinicaltrials.org/show/TCTR20250929011 ).
The authors' abstract, as published at the source. PLoS ONE, 2026 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Cell Biology
Cell BiologyBiochemistry, Genetics and Molecular Biology